Understanding Hereditary and Familial Prostate Cancer

Hearing that your prostate cancer might be “in the family” often triggers a spiral of worry about the future. However, understanding the specific category of your diagnosis can provide a clear roadmap for your care. While family history is a significant risk factor for developing the disease, it does not necessarily mean your cancer will be more aggressive or harder to treat than a “sporadic” case ^[1][2].

Defining Your Risk Category

Doctors generally divide prostate cancer into three categories based on how it appears in a family tree. It is important to note that the genetic mutations causing these cancers can be inherited from either your mother or your father—many men mistakenly overlook their maternal family history, such as aunts or grandmothers with breast or ovarian cancer ^[3].

• Sporadic Prostate Cancer: This is the most common form, accounting for about 80–85% of cases ^[3]. It occurs by chance, usually later in life, in men with no significant family history of the disease.
• Familial Prostate Cancer: This accounts for approximately 10–15% of cases ^[3]. It is defined by having at least one first-degree relative (father or brother) with the disease, but without a clear genetic mutation or a large cluster of cases ^[4]. This pattern often results from a combination of shared lifestyle or environmental factors (like diet or chemical exposures) and minor shared genetic traits.
• Hereditary Prostate Cancer: This is the rarest form, making up about 5–10% of cases ^[3]. It is often suspected if you have three or more affected relatives, or two relatives diagnosed before age 55 ^[4]. This form is frequently linked to specific, inherited germline mutations—changes in your DNA that you were born with—such as BRCA2, HOXB13, or ATM ^[5][6].

Impact on Your Prognosis

If you have been diagnosed with localized prostate cancer (cancer that hasn’t spread), having a family history may not be as daunting as it sounds. Research indicates that for men undergoing treatment like a radical prostatectomy (surgical removal of the prostate), a positive family history is not associated with an increased risk of biochemical recurrence (the PSA rising again after treatment) or cancer-specific death ^[7][2][8]. Essentially, once the cancer is diagnosed and treated, the “familial” tag often stops being an independent predictor of how well you will do ^[1].

Family History and Active Surveillance

For many men with low-risk cancer, active surveillance—monitoring the cancer closely rather than treating it immediately—is a standard option. If you have a family history, your medical team will look closer at your specific risk profile.

• Progression Risk: Some studies suggest that men with a strong family history may have a slightly higher risk of their cancer “upgrading” (showing more aggressive features) while on surveillance ^[9][10].
• The Role of Genetic Testing: If you carry specific high-risk mutations, such as BRCA2, you may be more likely to experience disease progression ^[11]. In these cases, your doctor might recommend more frequent monitoring or a shift toward active treatment earlier than for someone without those mutations ^[12][6].

Modern Guidelines and Testing

Current medical guidelines, including those from the NCCN, increasingly emphasize the role of multigene panel testing ^[13][14]. This is especially true if you have a significant family history or if your cancer has aggressive features. Identifying a pathogenic variant (a harmful mutation) doesn’t just help you; it provides vital information for your children and siblings regarding their own screening needs ^[15][16].

If you are concerned about your family history, the most empowering step is to document your family tree—including cases of breast, ovarian, and pancreatic cancer on both sides—and share it with your urologist.

In This Guide